Excipients & Specialty Ingredients
Contract Research Organization
Company Overview
About
Aminoverse B.V. is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Quality Control, Stability Testing, Method Development
Therapeutic Areas
Infectious Disease
Quick Facts
HQ:Netherlands
Founded:2019
Employees:2,223
Capabilities & Services
Core Capabilities
- Small Molecule API
- Small Molecule Drug Product
- Oral Solid Dose
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Oral Solid Dose
Production Scales
Pilot Scale
Phase I Clinical Trials
Clinical
Markets Served
North America
Europe
Regulatory Approvals
Drug Approval R6ERCP
FDA · #APR-BMTFJAD2 · 2018-03-01
Drug Approval 8UO437
Health Canada · #APR-TPBDHIXT · 2022-08-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-SZZ05REA
Issued: 2020-05-09
Expires: 2025-08-09
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-EAWA5B9Q
Issued: 2020-03-05
Expires: 2025-11-22
WHO GMP
World Health Organization
Cert #: CERT-DI07YHMN
Issued: 2020-08-03
Expires: 2025-02-12
Loading CDMO intelligence...
Key facts about Aminoverse B.V.
- Aminoverse B.V. is headquartered in the Netherlands.
- Aminoverse B.V. was founded in 2019.
- Aminoverse B.V. has 2,223 employees.
- Aminoverse B.V.'s capabilities include Small Molecule API, Small Molecule Drug Product and Oral Solid Dose.
Find CDMOs like Aminoverse B.V.
Directory pages this company appears in, each with the full list of matching manufacturers.